Orion Biotech Opportunities Corp (ORIA) Key Ratios
$10.23
$0.00 (0.00%)As on 17-May-2023 09:30EDT
Market cap
$256 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
29.2
P/B Ratio
1.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | 0.94 | 18.63 | -33.62 | -- | -- |
| Net Profit | 379.90 | 701.87 | -2,696.30 | -- | -- |
| EPS | 379.90 | 701.87 | 2,343.24 | -- | -- |
| Book Value | -- | -- | 4.70 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-22 | Dec-21 | Dec-20 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -- | -- | 9.66 | -- | -- |
| Return on Capital
| -- | -- | 9.66 | -- | -- |
| Return on Assets
| -- | -- | 9.10 | -- | -- |
| Debt to Equity (x)
| -- | -- | -- | -- | -- |
Profitability
ROCE
9.66
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
9.66
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
9.66
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
9.66
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
9.10
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
9.10
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-43.21
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
-43.21
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
2,343.23
--
Year on year growth in profit after tax
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
2,343.23
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
23.43
--
Year on year growth in earnings per share
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
23.43
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Current Ratio
6.50
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
6.50
|
16.57
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-0.05
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
-0.05
|
-6.52
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
2.73
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
2.73
|
-58.92
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.26
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
0.26
|
0.26
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-4.74
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
|
-4.74
|
-65.77
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|